Our pharmacist academic detailers are here to offer education in a new and engaging way. Academic detailing is a brief but dynamic (virtual or in-person) discussion on a clinical topic, personalized to the participant and their practice experience. Through unbiased, evidence-based information and resources, Illinois ADVANCE offers actionable tools to improve patient outcomes. Schedule your visit and experience the benefits of academic detailing firsthand.
Academic Detailers Heading link
Disclosures Heading link
The academic detailers, planning committee members, and reviewers who contributed to this program have no relevant financial conflicts of interest to disclose unless noted below.
- Academic detailer, Dr. Stewart Chung has stock ownership with companies Takeda and Silo Pharmaceutical.
- Academic detailer, Dr. Chintan Patel has stock ownership with companies: Abbvie, Caladrius Biosciences Inc, Clover Health Investments Corp, Diffusion Pharmaceuticals Inc, Dynavax Technologies Corp, EOM Pharmaceuticals, Esperion Therapeutics Inc, Gilead Sciences Inc, Glasko Smith Kline, Haleon, lmmunocellular Therapeutics, Motus GI Holdings Inc, Lisata Therapeutics Inc, Novabay Pharmaceuticals Inc, Novavax Inc, Ocugen Inc, Pfizer Inc, Protalix Biotherapeutics Inc, PuImatrix Inc, Quince Therapeutics Inc, Salarius Pharmaceuticals inc, Synthetic Biologics Inc, and Vaccinex Inc.
- Academic detailer, Dr. Sajitha Purathur has stock ownership with Pfizer.
- Academic detailer, Dr. Chirag Rathod has stock ownership with MindMed.
- Academic detailer, Dr. Jonathan Samardzich has stock ownership with Novavax, Northwest Biotherapeutics, Arcus Biosciences, and Tonix Pharmaceuticals.
- Academic detailer, Dr. Elaine Pimental has stock ownership with Catalyst Pharmaceuticals, Akebia Therapeutics, Tonix Pharmaceuticals, and Abbott.
- Academic detailer, Dr. Christina Petrykiw has stock ownership with Tempus AI.
- Academic detailer, Dr. Liana Osis has stock ownership with Moderna Inc.
All relevant financial relationships listed for the above academic detailers have been mitigated.